NCT02984878View on ClinicalTrials.gov

Multicenter Study to Evaluate the Safety and Efficacy of Revanesse® Ultra Retreatment

NACompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Nasolabial Fold Correction
Interventions
DEVICE

Revanesse Ultra

Nasolabial Fold correction

All Listed Sponsors
lead

Prollenium Medical Technologies Inc.

INDUSTRY

NCT02984878 - Multicenter Study to Evaluate the Safety and Efficacy of Revanesse® Ultra Retreatment | Biotech Hunter | Biotech Hunter